Johnson & Johnson Share Price Santiago S.E.

Equities

JNJCL

US4781601046

Pharmaceuticals

End-of-day quote Santiago S.E. 23:00:00 09/05/2024 BST 5-day change 1st Jan Change
155,930 CLP 0.00% Intraday chart for Johnson & Johnson 0.00% +14.33%

Financials

Sales 2024 * 88.37B 81,438B 7,037B Sales 2025 * 90.78B 83,659B 7,229B Capitalization 361B 332,482B 28,730B
Net income 2024 * 22.04B 20,310B 1,755B Net income 2025 * 23.09B 21,280B 1,839B EV / Sales 2024 * 4 x
Net cash position 2024 * 7B 6,448B 557B Net cash position 2025 * 21.07B 19,421B 1,678B EV / Sales 2025 * 3.74 x
P/E ratio 2024 *
16.8 x
P/E ratio 2025 *
15.9 x
Employees 131,900
Yield 2024 *
3.19%
Yield 2025 *
3.33%
Free-Float 77.07%
More Fundamentals * Assessed data
Dynamic Chart

Latest transcript on Johnson & Johnson

3 months+6.66%
6 months+9.81%
Current year+14.33%
More quotes
1 week
138 650.00
Extreme 138650
155 930.00
1 month
138 650.00
Extreme 138650
155 930.00
Current year
136 390.00
Extreme 136390
156 750.00
1 year
123 870.00
Extreme 123870
157 980.00
3 years
119 950.00
Extreme 119950
177 790.00
5 years
119 950.00
Extreme 119950
177 790.00
10 years
119 950.00
Extreme 119950
177 790.00
More quotes
Managers TitleAgeSince
Chief Executive Officer 61 31/12/88
Director of Finance/CFO 57 31/12/97
Chief Tech/Sci/R&D Officer 58 04/11/19
Members of the board TitleAgeSince
Director/Board Member 70 24/04/19
Director/Board Member 72 18/06/14
Director/Board Member 70 21/10/09
More insiders
Date Price Change
10/05/24 155,930 0.00%
09/05/24 155,930 0.00%
08/05/24 155,930 0.00%
07/05/24 155,930 0.00%

End-of-day quote Santiago S.E., May 09, 2024

More quotes
Johnson & Johnson is one of the world's leading producers of healthcare products. Net sales break down by family of products as follows: - pharmaceutical products (55.4%): drugs intended for the treatment of cardiovascular diseases, oncological diseases, gastro-intestinal illnesses, infectious, immunological, neurological, dermatological diseases, etc.; - medical products and equipment (28.9%): diagnostic systems, orthopedic and gynecological equipment, surgical materials, etc. for use by healthcare professionals; - consumer health products (15.7%): OTC drugs (Tylenol, Sudafed, Benadryl, Zyrtec, Motrin, Nicorette and other brands), health and beauty products (Aveeno, Clean & Clear, Dr. CI:Labo, Neutrogena and OGX), baby care products (Johnson's and Aveeno Baby), oral care products (Listerine), feminine hygiene products (Stayfree and Carefree and o.b.), wound care products (Band-Aid and Neosporin) etc. At the end of 2022, Johnson & Johnson has 89 manufacturing facilities located in the United States (28), North America (9), Europe (27), Africa and Asia/Pacific (25). Net sales are distributed geographically as follows: the United States (51.2%), Europe (24.7%), Asia/Pacific and Africa (17.7%) and other (6.4%).
More about the company
Trading Rating
Investor Rating
ESG Refinitiv
More Ratings
Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
22
Last Close Price
149.9 USD
Average target price
173.3 USD
Spread / Average Target
+15.58%
Consensus